江蘇雷利(300660.SZ):下游客户包括多家全球醫療器械龍頭企業,如邁瑞醫療、愛德士、西門子等
格隆匯7月3日丨江蘇雷利(300660.SZ)在投資者互動平台表示,公司在醫療領域積累了線性執行器、音圈電機等品類下多種型號的產品,下游客户包括多家全球醫療器械龍頭企業,如邁瑞醫療、愛德士、西門子等。公司已與邁瑞醫療建立戰略合作關係,共同推進醫療器械核心零部件國產化。公司在該領域具備產品性能優秀、系列齊全、全球市場認可度高、產品定製及技術研發能力突出等優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.